Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.24B |
| 2 |
Microsoft
MSFT
|
+$433M |
| 3 |
State Street Technology Select Sector SPDR ETF
XLK
|
+$419M |
| 4 |
State Street Health Care Select Sector SPDR ETF
XLV
|
+$332M |
| 5 |
RTX Corp
RTX
|
+$322M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
AABA
Altaba Inc
AABA
|
+$267M |
| 2 |
iShares Core US Aggregate Bond ETF
AGG
|
+$181M |
| 3 |
BCR
CR Bard Inc.
BCR
|
+$134M |
| 4 |
IQVIA
IQV
|
+$134M |
| 5 |
LVLT
Level 3 Communications Inc
LVLT
|
+$121M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 7.07% |
| 2 | Financials | 5.97% |
| 3 | Healthcare | 5.8% |
| 4 | Consumer Discretionary | 5.2% |
| 5 | Communication Services | 4.08% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3751
CALL
MBIA
MBI
$260M
| $510K | ﹤0.01% |
69,700
-61,700
| -47% | -$480K |
|
3752
Trustmark
TRMK
$2.75B
| $510K | ﹤0.01% |
16,008
+10,725
| +203% | +$354K |
|
|
INSY
3753
CALL
DELISTED
Insys Therapeutics, Inc.
INSY
| $510K | ﹤0.01% |
53,000
+52,700
| +17,567% | +$345K |
|
3754
Argan
AGX
$8.37B
| $509K | ﹤0.01% |
11,298
+3,699
| +49% | +$220K |
|
3755
Q2 Holdings
QTWO
$3.92B
| $509K | ﹤0.01% |
13,797
+9,637
| +232% | +$395K |
|
3756
V2X
VVX
$2.65B
| $509K | ﹤0.01% |
16,523
+2,571
| +18% | +$82.2K |
|
3757
Innospec
IOSP
$2.28B
| $508K | ﹤0.01% |
7,205
-11
| -0.2% | -$733 |
|
|
APRN
3758
DELISTED
Blue Apron Holdings, Inc. Class A Common Stock
APRN
| $508K | ﹤0.01% |
701
-52
| -7% | -$38.9K |
|
|
DBD
3759
DELISTED
Diebold Nixdorf Incorporated
DBD
| $508K | ﹤0.01% |
31,074
+28,324
| +1,030% | +$548K |
|
|
VER
3760
CALL
DELISTED
VEREIT, Inc.
VER
| $508K | ﹤0.01% |
13,040
-160
| -1% | -$6.42K |
|
|
RDC
3761
PUT
DELISTED
Rowan Companies Plc
RDC
| $507K | ﹤0.01% |
32,400
+7,200
| +29% | +$101K |
|
3762
ACI Worldwide
ACIW
$5.42B
| $506K | ﹤0.01% |
22,330
+12,977
| +139% | +$301K |
|
3763
FerroAtlántica
GSM
$839M
| $506K | ﹤0.01% |
31,229
-17,264
| -36% | -$267K |
|
|
CADE
3764
DELISTED
Cadence Bancorporation
CADE
| $505K | ﹤0.01% |
18,633
+13,624
| +272% | +$328K |
|
3765
Ichor Holdings
ICHR
$2.56B
| $504K | ﹤0.01% |
20,469
+14,611
| +249% | +$414K |
|
3766
Franco-Nevada
FNV
$46B
| $503K | ﹤0.01% |
6,296
-2,016
| -24% | -$162K |
|
3767
iShares Currency Hedged MSCI Emerging Markets
HEEM
$282M
| $503K | ﹤0.01% |
+18,996
| New | +$504K |
|
|
PPBI
3768
DELISTED
Pacific Premier Bancorp
PPBI
| $503K | ﹤0.01% |
12,557
-2,668
| -18% | -$105K |
|
3769
CALL
Sempra
SRE
$54.8B
| $503K | ﹤0.01% |
9,400
+3,000
| +47% | +$174K |
|
3770
Editas Medicine
EDIT
$442M
| $502K | ﹤0.01% |
16,313
+3,510
| +27% | +$88.4K |
|
3771
NovoCure
NVCR
$1.91B
| $502K | ﹤0.01% |
24,840
+13,512
| +119% | +$260K |
|
3772
Johnson Outdoors
JOUT
$505M
| $501K | ﹤0.01% |
8,070
+2,700
| +50% | +$189K |
|
3773
VirnetX Holding Corp
VHC
$63.1M
| $501K | ﹤0.01% |
6,768
+3,537
| +109% | +$344K |
|
3774
Kelly Services Class A
KELYA
$528M
| $500K | ﹤0.01% |
18,337
+17,630
| +2,494% | +$487K |
|
|
DBD
3775
CALL
DELISTED
Diebold Nixdorf Incorporated
DBD
| $499K | ﹤0.01% |
30,500
-9,600
| -24% | -$186K |
|
Similar funds
Barclays's Q4 2017 Portfolio in Review
As of Q4 2017, Barclays held 7,416 positions worth $122B, up 26% from $97.1B the previous quarter. Its ten largest holdings account for 24% of the portfolio.
Barclays deployed $19.9B of net new capital in Q4 2017, opening 435 new positions and adding to 3,853 existing holdings. Its largest new stake was iShares US Home Construction ETF: 198,606 shares worth $8.68M.
By sector, the portfolio is most concentrated in Technology at 7.1% of assets, up from 6.2% a quarter earlier, followed by Financials and Healthcare.
On the sell side, the largest reduction was Altaba Inc, an estimated $267M trimmed.
- Barclays's largest Q4 2017 buy was iShares US Home Construction ETF: 198,606 shares worth $8.68M.
- Barclays added most to State Street SPDR S&P 500 ETF Trust in Q4 2017, an estimated $1.24B increase.
- Barclays's biggest Q4 2017 reduction was Altaba Inc, cutting an estimated $267M.
- Barclays fully exited CR Bard Inc. in Q4 2017, selling an estimated $134M.
- Barclays's ten largest holdings make up 24% of its $122B portfolio in Q4 2017.
- Barclays opened 435 new positions and closed 356 in Q4 2017.
- Barclays's portfolio value rose 26% quarter-over-quarter to $122B.
Based on Barclays's 13F filing for Q4 2017, filed 14 Feb 2018.